09:49 AM EDT, 09/11/2025 (MT Newswires) -- Profusa ( PFSA ) said Thursday it is using Nvidia ( NVDA ) technology to build an artificial intelligence-driven physician portal for continuous biochemistry monitoring.

The company said it will combine its Lumee oxygen monitoring platform with Nvidia's ( NVDA ) NeMo to improve personalized data accuracy and provide real-time sensor data connections with electronic medical records.

The company said it expects to roll out the portal in the European Economic Area in early 2026.

Shares of Profusa ( PFSA ) were more than 79% higher in early trading Thursday.

Price: 0.48, Change: +0.21, Percent Change: +79.62